Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-Mullerian Hormone As A Predictor Of Live Birth For Patients With Unexplained Recurrent Pregnancy Loss.

JBRA assisted reproduction·2026
Same author

Identification and Documentation of Patient Social Risk Factors in the Prehospital Setting: A Pilot Implementation.

Prehospital emergency care·2026
Same author

Establishment and qualification of a GMP-compliant induced pluripotent stem cell master cell bank for clinical applications under the Korean MFDS framework.

Regenerative medicine·2026
Same author

Stigmasterol elicits antiviral activity against influenza viruses through virucidal and entry inhibition activity in vitro

BMB reports·2026
Same author

Molecular and clinical disparity of <i>EGFR</i>-mutant non-small cell lung cancer (NSCLC) based on histopathological stage and <i>EGFR</i> molecular subtypes.

Translational lung cancer research·2026
Same author

A plant gallotannin pentagalloyl d-glucose elicits antiviral activity against influenza A and B viruses through multi-targeting mechanisms.

Archives of virology·2026

Related Experiment Video

Updated: Jun 23, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.1K

Recent 5‑year trends in biliary tract cancer survival rates: An analytical big data survey.

Ji Yoon Lee1, Ju Won Kim2

  • 1Department of Biostatistics, Korea University College of Medicine, Seoul 02841, Republic of Korea.

Medicine International
|January 30, 2025
PubMed
Summary
This summary is machine-generated.

Biliary tract cancer (BTC) survival shows improvement, with outcomes influenced by cancer location and comorbidities like diabetes. Gallbladder cancer has a poorer prognosis compared to other BTC types.

Keywords:
big databiliary tract cancercholangiocarcinomarisk factorsurvival

More Related Videos

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

5.6K
Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach
13:57

Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach

Published on: May 23, 2025

92

Related Experiment Videos

Last Updated: Jun 23, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.1K
Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

5.6K
Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach
13:57

Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach

Published on: May 23, 2025

92

Area of Science:

  • Oncology
  • Epidemiology
  • Public Health

Background:

  • Biliary tract cancer (BTC), or cholangiocarcinoma, is a rare malignancy with historically poor prognosis.
  • Despite advances in chemotherapy and targeted therapies, comprehensive outcome research for BTC remains limited.
  • Understanding survival trends is crucial for improving patient management and treatment strategies.

Purpose of the Study:

  • To analyze survival trends in patients diagnosed with biliary tract cancer (BTC) between 2015 and 2020.
  • To investigate the impact of anatomical location and comorbidities on BTC patient mortality.
  • To assess changes in overall and 1-year mortality rates over the study period.

Main Methods:

  • Utilized anonymized data from a national public database, including 13,600 patients diagnosed with BTC.
  • Analyzed overall and 1-year mortality rates stratified by BTC anatomical site (intrahepatic, extrahepatic, gallbladder).
  • Assessed the influence of comorbidities (diabetes, hepatitis) and gallbladder stones on survival using hazard ratios (HR).

Main Results:

  • Overall survival showed improvement from 2018 onwards, with 1-year survival hazard ratios decreasing from 2015 to 2019.
  • Gallbladder cancer exhibited significantly lower 1-year survival rates (HR=0.349) compared to intrahepatic BTC.
  • Diabetes was associated with increased mortality (HR=1.318), while gallbladder stones showed a trend towards improved survival (HR=0.902).

Conclusions:

  • National big data analysis indicates an improving prognosis for biliary tract cancer patients since 2018.
  • BTC prognosis is significantly influenced by the cancer's anatomical location and the presence of comorbidities.
  • Co-existing conditions like diabetes negatively impact survival, underscoring the need for integrated patient care.